About Medvi
Los Angeles-based entrepreneur Matthew Gallagher founded the telehealth company Medvi, leveraging artificial intelligence to streamline its operations. Remarkably, he and his brother Elliot launched the entire venture in just two months with a modest initial investment of $20,000. The company focuses on supplying weight-loss drugs (GLP-1) and men's health treatments, operating with a lean team of only the two founders. This model highlights a growing trend in digital health, where small, tech-savvy teams can achieve massive scale.
Technology and Financial Performance
To build Medvi, Gallagher utilized a suite of AI tools, including:
- ChatGPT
- Claude
- Grok
- Midjourney
- Runway
The clinical and technical medical aspects are managed by Gallagher's partners: CareValidate and OpenLoop Health. This efficient strategy has yielded impressive financial results. For its first full fiscal year ending in 2025, Medvi is projected to generate $401 million in sales, with more ambitious targets aiming for $1.8 billion in the same year.
Furthermore, Medvi's net profit margin stands at 16.2% of revenue, translating to approximately $65 million last year. Gallagher notes that launching new service lines, such as men's health, takes only a few weeks, with a new product capable of attracting up to 50,000 customers in its first month. This demonstrates the remarkable speed and agility of Medvi within the competitive telehealth market.
The launch of Medvi reflects a broader industry trend where innovative technologies, particularly artificial intelligence, are playing a pivotal role in developing new healthcare services.
Amid rapidly growing demand for medical services, companies that harness modern technology to optimize their processes can gain significant competitive advantages. The success of Medvi may serve as a blueprint for other startups in the sector, showcasing the potential for rapid business scaling through the effective use of cutting-edge tools.